FDA’s ORA Undergoing Changes To Keep Up With Globalization – Glavin
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Regulatory Affairs will undergo "significant modifications" to its operations and structure to manage growing responsibilities amid shrinking resources, according to ORA Associate Commissioner Margaret O'K. Glavin